Sunita Radhakrishnan, MD

Cannabis remains problematic for glaucoma
Cannabis remains problematic for glaucomaDespite the legalization of marijuana by several state governments, physicians should not recommend smoking it as a treatment for glaucoma, said Sunita Radhakrishnan, MD. “It has been approved by public opinion rather than regulatory process,” she said.
Techniques for treating narrow angle glaucomaClinicians have a variety of tools and options at their disposal to treat narrow angle glaucoma. Sunita Radhakrishnan, MD, provided an overview of these possibilities.
Limited medical therapy drives impetus for product development
Understanding circadian patterns, drug efficacy could improve careKnowledge about the circadian pattern of IOP and the 24-hour efficacy of glaucoma medications is increasing, which is expected to improve medical management of glaucoma in the future.
Understanding medication circadian efficacy could improve careKnowledge about the circadian pattern of IOP and the 24-hour efficacy of glaucoma medications is increasing, which is expected to improve medical management of glaucoma in the future, reported Sunita Radhakrishnan, MD.
LPI a mainstay for angle-closure disease; but is it enough?Effectiveness depends on stage of the disease, mechanism of angle closure
LPI a mainstay for angle-closure disease, but often not enoughThe effectiveness of laser peripheral iridotomy in treating angle closure disease depends on the mechanism of angle closure (pupillary block versus non-pupillary block) and the stage of disease (primary angle closure suspect, primary angle closure, or primary angle closure glaucoma).